Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
6.43
+0.35 (5.76%)
At close: Oct 6, 2025, 4:00 PM EDT
6.45
+0.02 (0.31%)
After-hours: Oct 6, 2025, 5:17 PM EDT
Cybin Employees
Cybin had 50 employees as of March 31, 2025. The number of employees did not change compared to the previous year.
Employees
50
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,934,650
Market Cap
162.02M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 50 | 0 | - |
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CYBN News
- 13 days ago - Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones - Business Wire
- 25 days ago - CYBN Investors Have Opportunity to Join Cybin Inc. Fraud Investigation with the Schall Law Firm - Business Wire
- 25 days ago - Cybin to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit - Business Wire
- 4 weeks ago - Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment of Generalized Anxiety Disorder - Business Wire
- 4 weeks ago - Cybin to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - Business Wire
- 4 weeks ago - Cybin to Participate in the Cantor Global Healthcare Conference 2025 - Business Wire
- 4 weeks ago - Cybin Announces Senior Leadership Changes - Business Wire
- 5 weeks ago - Cybin Receives Australian Approval for EMBRACE, a Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder - Business Wire